Pancreatic cancer
Would you like to receive a message when there is new research on pancreatic cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research about Pancreatic cancer is available. View what Premium costs.
Publications and studies (2860)
- Vertebral body segmentation in CT: An open dataset, deep-learning models and comparison to existing models. (2026/07/30) ♡
- Synthesis & biological evaluation of novel sulfonyl hydrazone derivatives. (2026/07/30) ♡
- Early oral nutritional supplementation combined with graded functional exercise for postoperative recovery in patients undergoing pancreaticoduodenectomy. (2026/07/30) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Drain-tract seeding after Whipple resection: A reflection of pancreatic cancer biology. (2026/07/29) ♡
- Investigation of CRP and NLR as potential biomarkers for redefining biological borderline resectable pancreatic cancer. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma. (2026/07/28) ♡
- Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers. (2026/07/28) ♡
- Clinical outcomes of medical therapy, EUS-guided ethanol ablation, and surgical resection in insulinoma: a clinical epidemiology study. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up. (2026/07/27) ♡
- CD73 is associated with glycolysis related metabolic programs and CD8(+) T cell suppression in pancreatic ductal adenocarcinoma. (2026/07/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nodal metastasis from an occult duodenal gastrinoma amid an overlap of xanthogranulomatous and type 1 autoimmune pancreatitis: A case report. (2026/07/27) ♡
- The Association of Diabetes-Related Dietary Patterns with Pancreatic Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. (2026/07/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Limb Salvage in Acute Limb Ischemia and Diabetic Foot Gangrene Associated with Pancreatic Acinar Cell Carcinoma-Related Hypercoagulability. (2026/07/24) ♡
- A perioperative immunonutritional nomogram for survival prediction beyond tumor-node-metastasis classification in ampullary adenocarcinoma. (2026/07/24) ♡
- A novel multivariate framework for functional gene networks enrichment analysis. (2026/07/24) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Global landscape and knowledge structure of research on pancreatitis and gut microbiota: a bibliometric analysis based on WoSCC and Scopus (2006 - 2025). (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors. (2026/07/24) ♡
- Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting the deubiquitinase USP28 in cancer: navigating context-dependent mechanisms and therapeutic resistance. (2026/07/23) ♡
- Extracellular vesicles from cytokine-treated human pancreatic ductal cells enhance HLA class I expression in beta cells. (2026/07/23) ♡
- Stigma, stoma acceptance, quality of life among patients with colorectal cancer intestinal ostomy: a cross-sectional study. (2026/07/22) ♡
- Palliative gastrectomy or gastrojejunostomy for symptomatic stage IV gastric cancer: a dual center, retrospective, propensity matched cohort study. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapy-imprinted fibroblast memory in cholangiocarcinoma: rewiring CAF niches for immune evasion and treatment-resistant relapse. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic and therapeutic challenges with malignant biliary tract and periampullary pathology in post-bariatric surgery. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Evolution and precision trends of pancreaticojejunostomy in pancreaticoduodenectomy. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Patient-derived organoids in functional precision oncology: from experimental models to clinical decision-making. (2026/07/22) ♡
- Dietitian-led individualized pancreatic enzyme replacement therapy is associated with favorable nutritional and immune-inflammatory profiles in pancreatic cancer: a retrospective cohort study. (2026/07/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D Status and Gastroenteropancreatic Neuroendocrine Neoplasms: Biological Rationale, Clinical Associations and Limitations of Current Evidence. (2026/07/20) ♡
- Insulin gene-modified 3D stem cells for enhanced islet regeneration and systemic reversal of type 1 diabetes. (2026/07/20) ♡
- Dual-wavelength-responsive GMMC-Pdots-Ag hydrogel for spatiotemporally controlled photothermal and hydrogen therapy of infected liver and skin defects. (2026/07/20) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. [(177)Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial. (2026/07/18) ♡
- Diagnostic Performance of Fecal Elastase and Risk Factors for Exocrine Pancreatic Insufficiency in Children with Pancreatitis: An INSPPIRE-2 Study. (2026/07/18) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Is It Time to Revisit Radiotherapy for Unresectable Pancreatic Cancer? (2026/07/16) ♡
- PRSS1(A16V) germline mutation is common in a cohort of intraductal papillary mucinous neoplasms of the pancreas. (2026/07/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Laparoscopic resection of pedunculated extraluminal gastrointestinal stromal tumor (GIST) from gastric greater curvature: a case report and review of literature. (2026/07/15) ♡
- Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data. (2026/07/15) ♡
- Percutaneous abdominal lavage cytology screening reduces non-therapeutic laparotomy in patients with pancreatic cancer considered for curative-intent resection: A single-institutional retrospective study. (2026/07/15) ♡
- Specific diagnostic value of systemic immune-inflammation indices combined with nutritional and tumor markers in the stage diagnosis of pancreatic cancer: a retrospective cohort study. (2026/07/15) ♡
- Assessment of planning organ at risk volume margins in non-adaptive pancreatic stereotactic body radiotherapy. (2026/07/15) ♡
- Practice patterns of endoscopic ultrasound-guided tissue acquisition of solid pancreatic masses: an international survey study. (2026/07/14) ♡
- Nonstop gated cone-beam computed tomography for respiratory gating pancreatic cancer radiotherapy using dual-domain deep learning reconstruction. (2026/07/14) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Primary pancreatic paraganglioma: a systematic review. (2026/07/13) ♡
- Distal pancreatectomy for neuroendocrine neoplasms in patients with multiple endocrine neoplasia type 1. (2026/07/13) ♡
- Immune Checkpoint Inhibitor Outcomes Across Child-Pugh A, B, and C Hepatocellular Carcinoma: A Real-World Integrated Health-System Cohort. (2026/07/11) ♡
- Anthropometric traits, metabolic biomarkers, and pancreatic cancer risk: a causal mediation analysis in UK Biobank. (2026/07/11) ♡
- Right Ventricular Failure From Malignant Pulmonary Artery Compression. (2026/07/09) ♡
- Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer. (2026/07/09) ♡
- Estimation of Resting Energy Expenditure in Patients Undergoing Total or Partial Pancreatectomy for Pancreatic Tumors. (2026/07/08) ♡
- Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. (2026/07/06) ♡
- hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation. (2026/07/06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.